What EBITDA multiples are typical for San Diego mid-market companies?

Multiples vary significantly by sector and business quality. Defense and government services companies typically trade at 5–9x EBITDA, with contract diversity and re-compete history as primary multiple drivers. Technology and SaaS companies command higher multiples when revenue is recurring and retention is strong. Biotech and life sciences valuations are more milestone-driven at earlier stages and acquisition-synergy-driven at later stages. Business quality factors — revenue concentration, management depth, margin stability — affect multiples across all sectors.

How does revenue concentration affect business valuation in San Diego?

Revenue concentration — where a high percentage of revenue comes from a single customer, contract, or program — is the most consistently cited valuation risk factor in San Diego's primary sectors. Defense companies with single-contract concentration, biotech companies with single-platform exposure, and professional services firms with single-client dependence all face valuation discounts relative to better-diversified peers. KCENAV's Valuation Optimizer directly scores concentration risk and its multiple impact.

What is the single most impactful thing a San Diego company can do to improve its valuation?

The highest-impact action is almost always reducing the largest single source of concentration — whether that's customer, contract, channel, or founder. Buyers pay significantly more for businesses where no single relationship controls more than 20–25% of revenue. The specific actions required depend on which type of concentration is most acute, which is what KCENAV's Valuation Optimizer identifies.

How long before a planned exit should a San Diego company start working on valuation?

Three years is the minimum to meaningfully move the needle on the factors that drive multiples. Many of the highest-impact improvements — reducing revenue concentration, installing management depth, building recurring revenue — require at minimum two to three years to demonstrate in financials. Starting earlier gives more options and better outcomes.

Business Valuation in San Diego | What Drives Mid-Market Multiples

How San Diego's Sector Mix Shapes Valuations

Business valuation is not a formula. It is a judgment about future cash flow durability, and that judgment is heavily informed by sector-specific risk factors. In San Diego, the sector mix creates a range of valuation environments that require different analysis frameworks to navigate.

Defense and government contracting companies trade on contract quality and diversification. The fundamental question buyers ask is: how confident am I that this revenue continues after I own it? Companies with diversified contract vehicles — multiple agencies, multiple program offices, demonstrated re-compete history — command meaningfully higher multiples than companies dependent on a single award. The EBITDA multiple range in this sector is wide, and the spread between the bottom and top of the range is almost entirely explained by concentration and contract quality.

Biotech and life sciences companies present a different valuation challenge. Pre-revenue and early-commercial companies are valued on milestone-driven frameworks and strategic acquisition synergies. Mid-market life sciences companies with established revenue bases are typically valued on a combination of revenue multiple, pipeline optionality, and the attractiveness of the platform to strategic acquirers in the global pharmaceutical and medtech ecosystem. The San Diego market has produced numerous biotech acquisitions, and the acquirer pool is active and experienced.

Technology and SaaS companies in San Diego increasingly trade on recurring revenue quality — ARR, net revenue retention, customer acquisition economics. The broader market for SaaS multiples has normalized from its 2021 peaks, but companies with strong retention, low concentration, and defensible competitive positions continue to command premium multiples from both strategic and financial buyers.

Professional services companies — including defense-adjacent services, healthcare services, and business services — tend to trade on normalized EBITDA multiples that are most directly affected by founder dependency and customer concentration. These are the two factors that buyers price most aggressively in professional services.

The Universal Multiple Drivers Across San Diego Sectors

Regardless of sector, several factors consistently drive EBITDA multiples up or down across San Diego's mid-market:

Revenue concentration is the most consistently cited risk factor. A business where a single customer, contract, or program represents more than 20–30% of revenue carries a concentration discount that is real and measurable. Buyers in every sector model the scenario where that relationship ends — and price accordingly.

Management depth and founder dependency directly affects how buyers model transition risk. A company that operates independently of its founder — with documented processes, strong operational leadership, and genuine management team continuity — is demonstrably worth more than one where key relationships and decisions flow through a single individual. KCENAV's diagnostics score this directly.

Revenue quality and recurring characteristics — contract structures, retention rates, renewals, and the stickiness of customer relationships — matter to every acquirer class. Businesses that demonstrate predictable, recurring revenue characteristics command meaningfully higher multiples than those with project-based or transactional revenue.

Margin stability is evaluated against sector benchmarks. Buyers pay attention to whether margins are improving or compressing, and whether margin compression is structural (pricing power loss, customer mix shift) or temporal (investment in growth). Clean, improving margins in a defensible business are a strong signal.

How KCENAV's Valuation Optimizer Works

KCENAV's Valuation Optimizer is a 14-question diagnostic that scores your company across seven valuation pillars: financial performance, revenue quality, competitive position, operational scalability, management depth, customer retention, and growth trajectory. The output includes a 0–100 score, a letter grade, and an estimated EBITDA multiple range benchmarked against verified mid-market transaction data.

Critically, the diagnostic provides a prioritized roadmap of the specific improvements — by impact and by gap — that would have the highest effect on your multiple. This is actionable information, not a general assessment. San Diego business owners use it to prioritize the work most worth doing in the years before a planned transaction.